Estimate Recalculated May 20, 2025 11:47PM EST
Michelle Renee Griffin has an estimated net worth of $3.43 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, PHASERX, INC., Trubion Pharmaceuticals, Inc, CHINOOK THERAPEUTICS, INC., HTG MOLECULAR DIAGNOSTICS, INC, SONUS PHARMACEUTICALS INC, Acer Therapeutics Inc., DENDREON CORP, and CORIXA CORP.
Michelle Renee Griffin's CIK is 0001229765
2021 was Michelle Renee Griffin's most active year for acquiring shares with 15 total transactions. Michelle Renee Griffin's most active month to acquire stocks was the month of April. 2005 was Michelle Renee Griffin's most active year for disposing of shares, totalling 23 transactions. Michelle Renee Griffin's most active month to dispose stocks was the month of June. 2005 saw Michelle Renee Griffin paying a total of $639,499.26 for 364,974 shares, this is the most they've acquired in one year. In 2005 Michelle Renee Griffin cashed out on 729,591 shares for a total of $932,214.80, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!